PHARMACOLOGICAL HYPOGONADOTROPISM CAN BE USED TO ADVANTAGE FOR OVULATION INDUCTION PROTOCOLS

Ovarian stimulation with hMG/hCG is an established therapeutic principle in anovulatory patients with amenorrhea, low gonadotropins and a negligible endogenous estrogen production. Exogenous gonadotropins are also used for ovarian stimulation in women who are not typical candidates for this type of treatment, i.e. those with anovulatory cycles and in cases of luteal insufficiency which do not respond to clomiphene. In addition, exogenous gonadotropins are given to patients who are to be prepared for intrauterine insemination, in vitro fertilization (IVF) or gamete intrafallopian transfer (GIFT) in order to achieve multifollicular development.